Ovarian Cancer Prevention, Detection, and Treatment of the Disease and its Recurrence. Molecular Mechanisms and Personalized Medicine Meeting Report

被引:49
作者
Modugno, Francesmary [1 ,2 ,3 ,4 ]
Edwards, Robert P. [1 ,3 ,4 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
[3] Magee Womens Res Inst, Womens Canc Res Ctr, Pittsburgh, PA USA
[4] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
关键词
Ovarian neoplasms; Epidemiology; Etiology; Screening; Biomarkers; Proteomics; Genomics; Metabalomics; BRCA1/2; Cancer stem cells; Micro RNA; Nuclear receptors; Individualized medicine; Cancer vaccines; Quality of life; Patient reportable outcomes; Therapeutics; Clinical trials; Survival; WOMEN; RISK;
D O I
10.1097/IGC.0b013e31826bd1f2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To review the current understanding of the underlying molecular, biologic, and genetic mechanisms involved in ovarian cancer development and how these mechanisms can be targets for prevention, detection, and treatment of the disease and its recurrence. Methods: In May 2012, we convened a meeting of researchers, clinicians, and consumer advocates to review the state of current knowledge on molecular mechanisms and identify fruitful areas for further investigations. Results: The meeting consisted of 7 scientific sessions ranging from Epidemiology, Early Detection, and Biology to Therapeutics and Quality of Life. Sessions consisted of talks and panel discussions by international leaders in ovarian cancer research. A special career development session by the Congressionally Directed Medical Research Program Department of Defense Ovarian Cancer Academy as well as an oral abstract and poster session showcased promising new research by junior scientists. Conclusions: Technological advances in the last decade have increased our knowledge of the molecular mechanisms involved in a host of biological activities related to ovarian cancer. Understanding the role these mechanisms play in cancer initiation and progression will help lead to the development of prevention and treatment modalities that can be personalized to each patient, thereby helping to overcome this highly fatal malignancy.
引用
收藏
页码:S45 / S57
页数:13
相关论文
共 24 条
[1]   The Origin of Ovarian Carcinomas: A Unifying Hypothesis [J].
Auersperg, Nelly .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (01) :12-21
[2]   Women's cancer survivorship: Time to gear up! [J].
Bodurka, Diane C. ;
von Gruenigen, Vivian E. .
GYNECOLOGIC ONCOLOGY, 2012, 124 (03) :377-378
[3]   Patient-Reported Outcomes Clinical Trials in Ovarian Cancer [J].
Carey, Mark S. ;
Gotay, Carolyn .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) :782-787
[4]  
Chambers SK, 2009, FUTURE ONCOL, V5, P1429, DOI [10.2217/fon.09.103, 10.2217/FON.09.103]
[5]   Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton [J].
Flint, Melanie S. ;
Budiu, Raluca A. ;
Teng, Pang-ning ;
Sun, Mai ;
Stolz, Donna B. ;
Lang, Megan ;
Hood, Brian L. ;
Vlad, Anda M. ;
Conrads, Thomas P. .
BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (06) :1187-1196
[6]   Endometriosis [J].
Giudice, LC ;
Kao, LC .
LANCET, 2004, 364 (9447) :1789-1799
[7]   A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 [J].
Goode, Llen L. ;
Chenevix-Trench, Georgia ;
Song, Honglin ;
Ramus, Susan J. ;
Notaridou, Maria ;
Lawrenson, Kate ;
Widschwendter, Martin ;
Vierkant, Robert A. ;
Larson, Melissa C. ;
Kjaer, Susanne K. ;
Birrer, Michael J. ;
Berchuck, Andrew ;
Schildkraut, Joellen ;
Tomlinson, Ian ;
Kiemeney, Lambertus A. ;
Cook, Linda S. ;
Gronwald, Jacek ;
Garcia-Closas, Montserrat ;
Gore, Martin E. ;
Campbell, Ian ;
Whittemore, Alice S. ;
Sutphen, Rebecca ;
Phelan, Catherine ;
Anton-Culver, Hoda ;
Pearce, Celeste Leigh ;
Lambrechts, Diether ;
Rossing, Mary Anne ;
Chang-Claude, Jenny ;
Moysich, Kirsten B. ;
Goodman, Marc T. ;
Doerk, Thilo ;
Nevanlinna, Heli ;
Ness, Roberta B. ;
Rafnar, Thorunn ;
Hogdall, Claus ;
Hogdall, Estrid ;
Fridley, Brooke L. ;
Cunningham, Julie M. ;
Sieh, Weiva ;
McGuire, Valerie ;
Godwin, Andrew K. ;
Cramer, Daniel W. ;
Hernandez, Dena ;
Levine, Douglas ;
Lu, Karen ;
Iversen, Edwin S. ;
Palmieri, Rachel T. ;
Houlston, Richard ;
van Altena, Anne M. ;
Aben, Katja K. H. .
NATURE GENETICS, 2010, 42 (10) :874-+
[8]   Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics [J].
Gross, Amy L. ;
Kurman, Robert J. ;
Vang, Russell ;
Shih, Ie-Ming ;
Visvanathan, Kala .
JOURNAL OF ONCOLOGY, 2010, 2010
[9]   High-grade serous ovarian cancer arises from fallopian tube in a mouse model [J].
Kim, Jaeyeon ;
Coffey, Donna M. ;
Creighton, Chad J. ;
Yu, Zhifeng ;
Hawkins, Shannon M. ;
Matzuk, Martin M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (10) :3921-3926
[10]   Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship [J].
Kindelberger, David W. ;
Lee, Yonghee ;
Miron, Alexander ;
Hirsch, Michelle S. ;
Feltmate, Colleen ;
Medeiros, Fabiola ;
Callahan, Michael J. ;
Garner, Elizabeth O. ;
Gordon, Robert W. ;
Birch, Chandler ;
Berkowitz, Ross S. ;
Muto, Michael G. ;
Crum, Christopher P. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (02) :161-169